LLNI Funded Publications
We are incredibly proud of every publication that LLNI funding has contributed to.
Publishing and sharing this information and data is integral to finding answers for the future.
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms.
Other Authors: McPherson S, Mills K, McMullin MF,
Journal:Journal of translational medicine
Date: December 2018